Find an expert
Our panel of editors are available for interview
Professor Stephen Kaye
Editor-in-Chief BMJ Open Ophthalmology
Professor of Ophthalmology, Institute of Life Course and Medical Sciences, University of Liverpool where he leads the research into infections of the eye, Consultant Ophthalmologist Royal Liverpool University Hospital where he leads the Cornea and Ocular Surface Disease Service, Vice President of The Royal College of Ophthalmologists, Director of The Liverpool Research Eye Biobank, NHS England National lead for Corneal Transplantation, Honorary Professorship, Queens University, Belfast.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Dr Nick Brown
Editor-in-Chief of Archives of Disease in Childhood
Dr Nick Brown is a paediatrician and epidemiologist. His initial training was in the UK in general paediatrics, but for the last 25 years, he has had a parallel carer in academic international child health. Nick has lived and worked in Sudan, Afghanistan, Papua New Guinea, India and Pakistan, largely as an epidemiologist. He has a long affiliation with the Aga Khan University in Karachi where he teaches epidemiology, biostatistics and research methodology and is involved in studies in child pneumonia, rheumatic heart disease, thalassaemia and early child development. Nick is currently based in Sweden with a clinical position in Gavle and academic affiliation with the International Centre for Maternal and Child Health at Uppsala University.
Professor Anna Maria Geretti
Editor-in-Chief of Sexually Transmitted Infections
Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases at the Institute of Infection & Global Health of the University of Liverpool, and Honorary Consultant at the Royal Liverpool University Hospital. She trained in Italy, the Netherlands and the UK and has a special interest in HIV, hepatitis B and hepatitis C infection. She has published over 100 peer-reviewed articles, editorials, reviews and book chapters, runs capacity building programmes for resource-limited countries and enthusiastically shares her expertise to train doctors and scientists.
Professor Hans Kromhout
Editor-in-Chief of Occupational & Environmental Medicine
Professor Hans Kromhout is an occupational hygiene and epidemiology specialist, based at the Institute for Risk Assessment Sciences at Utrecht University in the Netherlands. Professor Kromhout’s work has covered the health effects of chemical and physical (EMF) agents in the workplace and general environment. He has been the (co-)PI of large international studies in among others the asphalt industry, rubber manufacturing industry, industrial minerals industry, health sector and agriculture and community based studies on cancer, respiratory diseases, neurodegenerative diseases and reproductive health effects.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.